Open to all compounders

In advance of the April 1, 2023, enforcement date for the new animal compounding guidance from FDA, APC and PCCA are partnering to offer a CE webinar aimed at helping you bring your animal compounding operations into compliance–and to make sure the veterinarians you work with understand the changes required by GFI 256.

All compounding pharmacists, technicians and other compounding team members are invited to join PCCA Vice President of Clinical Services A.J. Day, PharmD, and PCCA Director of Clinical Services Matt Martin, PharmD, BCSCP, to learn what’s new in GFI 256 and what you need to know now.

Learning objectives:

• Describe the legal framework that GFI 256 discusses for animal drugs.
• Identify the parameters for compounding patient specific animal medications in GFI 256.
• Illustrate how to differentiate a compounded animal medication from a copy of a manufactured drug product.
• Analyze situations when compounding from a manufactured drug product can produce an unacceptable final compounded preparation.
• Review the criteria for compounding for office stock and how drugs can become eligible for FDA’s list related to this.

Program details:

• March 22 • 12pm – 1pm CT
• Cost: $25 per person. with the proceeds going to APC
• Register here

Purchase includes:

• CE = 1 hour (Must be claimed within 14 days of the live event.)
• Recording available to paid registrants for 3 months post-live event.

Click here to learn more and register.